1. Home
  2. NX vs LXRX Comparison

NX vs LXRX Comparison

Compare NX & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$15.42

Market Cap

852.1M

Sector

Industrials

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.90

Market Cap

703.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
LXRX
Founded
1927
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
852.1M
703.3M
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
NX
LXRX
Price
$15.42
$1.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$28.00
$4.15
AVG Volume (30 Days)
312.5K
3.2M
Earning Date
06-04-2026
05-01-2026
Dividend Yield
1.64%
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
$1,837,641,000.00
$49,803,000.00
Revenue This Year
$4.26
N/A
Revenue Next Year
$1.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.81
60.24
52 Week Low
$11.04
$0.64
52 Week High
$22.90
$2.53

Technical Indicators

Market Signals
Indicator
NX
LXRX
Relative Strength Index (RSI) 31.35 44.54
Support Level $15.57 $1.52
Resistance Level $20.81 $1.95
Average True Range (ATR) 0.82 0.14
MACD -0.12 -0.05
Stochastic Oscillator 3.21 17.35

Price Performance

Historical Comparison
NX
LXRX

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: